Posted on 11/15/18
Bicycle Therapeutics Named Best New Drug Developer at 2018 World ADC Awards
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycles®) product platform, today announced . . .
Posted on 11/15/18
Plymouth Orthodontics Announces Grand Opening
Dr. Karla AlvaradoDr. Karla M. Alvarado, DMD, MSD is excited to announce the launch of Plymouth Orthodontics (www.plymouth-orthodontics.com), now open at 51 Long Pond Road in . . .
Posted on 11/14/18
Aldeyra Therapeutics Announces Third Quarter 2018 Financial Results
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced . . .
Posted on 11/14/18
Moderna Seeks $500 Million In IPO
SummaryModerna has filed to raise $500 million in a very large biopharma IPO.The firm is advancing a large pipeline of mRNA-based treatments for a wide variety . . .
Posted on 11/14/18
Biogen: Spinning Around Spinraza
SummaryBiogen is a solid biotech company with established revenue streams and strong financials.The short-term growth of the company is heavily dependent on Spinraza's ex-US sales.We are . . .
Posted on 11/14/18
Massachusetts Dental Society Inks Exclusive Partnership with Bento
The Massachusetts Dental Society (MDS), a statewide organization serving approximately 5,000 member dentists, has named Bento, a dental benefits management software platform, as an exclusive partner . . .
Posted on 11/14/18
Akebia Therapeutics Sends Letter to Shareholders
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq: AKBA) mailed a letter to Akebia shareholders in connection with the special meeting of Akebia shareholders (the “Special Meeting”) that . . .
Posted on 11/13/18
Dana-Farber Cancer Institute and Deerfield Collaborate
Dana-Farber Cancer Institute and Deerfield Management announced today an up to $80 million collaboration to create the Center for Protein Degradation at Dana-Farber. The goal of . . .
Posted on 11/13/18
Kymera Therapeutics Announces $65 Million Series B
Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to create breakthrough medicines for patients
Posted on 11/13/18
Profound Treatment Named "New Treatment of the Year" By MyFaceMyBody Awards USA
Candela Corporation, a leading global aesthetic device company, announces that the Profound treatment has been named "New Treatment of the Year" by The Global Aesthetic Awards, . . .
Posted on 11/13/18
Anthem Blue Cross and Blue Shield and Walmart Collaborate
SOUTH PORTLAND, Maine--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield in Maine (Anthem) will be working with Walmart to give 2019 Medicare Advantage (MA) plan consumers the . . .
Posted on 11/13/18
Catabasis Pharmaceuticals Announces Collaboration with the University of Texas Southwestern
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced a collaboration with Pradeep Mammen, MD, FACC, FAHA, founder and Medical Director of the . . .
Posted on 11/13/18
Jounce Therapeutics Reports Third Quarter 2018 Financial Results
CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer . . .
Posted on 11/13/18
Solid Biosciences Reports Third Quarter 2018 Financial Results And Provides Business Update
CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) today reported financial results for the third quarter ended September 30, 2018 and . . .
Posted on 11/13/18
Albireo Reports Third Quarter 2018 Financial Results
BOSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced . . .
Posted on 11/13/18
Athenahealth, Inc. Profits Soar While It Waits for a Buyer
When athenahealth, Inc. (NASDAQ:ATHN) reported its second-quarter results on July 31, 2018, the big question related to how quickly the company might be acquired. More than . . .
Posted on 11/13/18
Aetna Medicare HMO Plans in Pennsylvania Awarded High-Quality Rating
HARTFORD, Conn.--(BUSINESS WIRE)--Aetna’s (NYSE: AET) Medicare Advantage Prescription Drug (MAPD) HMO plan serving the state of Pennsylvania has been awarded 4.5 stars out of 5 by . . .
Posted on 11/13/18
Leap Therapeutics Reports Third Quarter 2018 Business Update and Financial Results
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported a business update and financial results for the third quarter ended . . .
Posted on 11/13/18
Curaleaf Opens Its 15th Medical Marijuana Dispensary in Florida
Curaleaf Holdings, Inc. (CSE: CURA), a leading vertically integrated cannabis operator in the United States, announced today that the Company has opened its 15th medical marijuana . . .
Posted on 11/13/18
HealthyCapital Recognized as One of Healthcare & Wellness Industry's Most Innovative Companies
HealthyCapital (www.healthycapital.com), a joint venture between HealthView Services and Mercy, named one of the top five large U.S. health systems for the past three years by . . .
Posted on 11/12/18
Athenahealth Sale Sealed for $5.5B
According to Reuters, P-E player Veritas Capital and hedge fund Elliott Management have teamed to purchase Athenahealth (NASDAQ:ATHN) for $5.5B in cash, or roughly $135 per . . .
Posted on 11/9/18
Wave Life Sciences Reports Q3 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, . . .
Posted on 11/9/18
AVEO Reports Third Quarter 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today reported financial results for the third quarter ended September 30, 2018 and provided a business update.“The recent announcement of positive . . .
Posted on 11/9/18
Leap Therapeutics Reports Third Quarter 2018 Business Update and Financial Results
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported a business update and financial results for the third quarter ended . . .
Posted on 11/9/18
Innovation Pharmaceuticals Provides Corporate Update
BEVERLY, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX), a clinical stage biopharmaceutical company, is pleased to provide a corporate update highlighting business development . . .

